"I'm just 'Thinking outside the square.'"
I wonder what happens to all the expertise that has been gathered to develop Duravr if Anteris is taken out by one of the big players. We have a great team of staff, advisory Board members, engineers and others and it would be a shame to see them disbanded if there are other challenges they could address. The following is from the MST report -
My thinking outside the square is that Anteris will continue in existence and pursue other opportunities as a structural heart company. Your suggestion of a hook up with 4C Medical might not be the best option for the TAVR project but there could be other opportunities with 4C -
4C Medical Technologies, Inc. is conducting a clinical research study to evaluate the safety and performance of a new device for the treatment of severe mitral regurgitation (MR), AltaValve.
As a minor shareholder I will just tag along for the ride and remain patient.
- Forums
- ASX - By Stock
- CEO presentation - one of the best I have seen.
"I'm just 'Thinking outside the square.'"I wonder what happens...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.20 |
Change
-0.290(2.32%) |
Mkt cap ! $257.9M |
Open | High | Low | Value | Volume |
$12.49 | $12.50 | $11.80 | $396.0K | 32.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 923 | $11.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.20 | 1821 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 923 | 11.800 |
1 | 80 | 11.750 |
2 | 772 | 11.600 |
2 | 2000 | 11.500 |
1 | 1500 | 11.350 |
Price($) | Vol. | No. |
---|---|---|
12.200 | 1821 | 1 |
12.300 | 3000 | 1 |
12.850 | 99 | 1 |
13.000 | 2000 | 1 |
13.300 | 200 | 1 |
Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |